Utah Medical Products (UTMD) Q1 2026 Earnings
UTMD·Reported April 23, 2026·Before market open
Utah Medical Products reported Q1 2026 revenue of $8.7M (-10.2% YoY). Diluted EPS came in at $0.82 (-10.9% YoY).
Revenue
$8.7M
Diluted EPS
$0.82
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Utah Medical Products's Q1 2026 earnings report.
Utah Medical Products (UTMD) reported Q1 2026 earnings on April 23, 2026 before market open.
Utah Medical Products reported revenue of $8.7M and diluted EPS of $0.82 for Q1 2026.
Compared to the same quarter a year prior, revenue declined 10.2% from $9.7M a year earlier and diluted EPS declined 10.9% from $0.92.
You can read the 8-K earnings release (0001096906-26-000602) and the 10-Q periodic report (0001096906-26-000767) directly on SEC EDGAR. The filing index links above go to sec.gov.